New blog!💻 Dr Jamie Lopez Bernal, Consultant Epidemiologist for Immunisation, UK Health Security Agency, explores the risk COVID-19 and Flu pose for people living with long term conditions, and how accessing vaccines can help people get #WinterStrong💉 👉bit.ly/47FIw1V

Immunotherapy is reshaping cancer research—but challenges remain. Join us at #CSCancerImmunity2025 Keynotes: Ira Mellman (Parker Institute for Cancer Immunotherapy) and Carl June (Penn). Early-bird registration discount Sept 19! hubs.li/Q03Hj7sn0

Antibiotic therapy for severe bacterial infections | Intensive Care Medicine link.springer.com/article/10.100…

Among adults with complicated Staphylococcus aureus bacteremia, dalbavancin was not superior to standard therapy, though both treatments demonstrated similar efficacy and safety profiles. 🧵 ja.ma/467gMnT

✨ Impulsamos la ciencia médica. Nos reunimos con hospitales que pertenecen a la @Salud_Cz9 para construir un reglamento de investigación en unidades asistenciales docentes. 🚀 Un paso firme hacia una medicina basada en evidencia y al servicio del país. 🧬📚 Ministerio de Salud Pública 🇪🇨

WHO/UNICEF estimates of national immunization coverage who.int/news-room/ques…

Early impact of RSV vaccination in older adults in England - The Lancet thelancet.com/journals/lance…

Improved understanding of the evolution of pandemic vaccination programmes and waning immunity Development of improved monitoring systems Development of approaches and commitment to rapid vaccine development

Excelente !!!

instagram.com/p/DOcTkTxAsEo/…

Pendientes ….. Gracias ESCMID #Vaccines

Debemos salir del contexto de edad para priorización de vacunas, el contexto demográfico global es claro tenemos que extender la vacunación a población vulnerable y adulta en general… eso esquidad la IA puede ayudar Ricardo B. Leite

Por qué necesitamos pronto una vacuna contra el Virus del Epstein Barr VEB ESCMID #Vaccines

Grupo placebo vs control de nnmodeloa animales vacunados contra gp350 -FNP (VEB) … en el grupo de vacunados no linfoma…. ESCMID #vaccines

Looking to the future ya están los primeros estudios en fase I para la vacuna contra VEB 🫶🏻otra vacuna que va a prevenir el cáncer!

Thank you to everyone who made the 6th #VaccinesConference a major success. Our partners EMA, ESPID, EAHP helped create a fantastic programme which we hope you all enjoyed. The conference material will be available on ESCMID media soon for ESCMID members and conference attendees.

Metabolic Signatures of Post-Viral Syndromes: Insights from Long COVID, Experimental Models, and Comparative Studies ‼️Interesting and thorough PhD THESIS from the UK, sit down, take some coffee( or a beer David Joffe MB BS (Hons), PhD, FRACP 🇦🇺 😂 ) and ......... read at your leisure! ➡️"Post-viral

𝐈𝐦𝐦𝐮𝐧𝐨𝐬𝐮𝐩𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 is the inhibition of unwanted immune responses that, in the context of allo-transplantation, would otherwise result in the rejection of a foreign (or histoincompatible) organ or cellular graft. Immunosuppressive drugs are also used to treat